An official website of the United States government

Search
Filters

Study Acronym

DPPOS

1 - 17 of 17 Results
  • Previous
  • 1(current)
  • Next
Page
Show:
Study Search Results Table
Title
PMID
PMCID
Public Release Type
Publication Year
DOI
Study Acronym
Request ID(s)
Public Release Origin
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.19878986PMC3135022Journal200910.1016/S0140-6736(09)61457-4DPPOSContributing Study
A long-term mechanistic computational model of physiological factors driving the onset of type 2 diabetes in an individual.29444133PMC5812629Journal201810.1371/journal.pone.0192472DPPOS, DPP20879Secondary Research
A nomogram-based diabetic sensorimotor polyneuropathy severity prediction using Michigan neuropathy screening instrumentations34715551Journal202110.1016/j.compbiomed.2021.104954DPPOS23125Secondary Research
Assessing Heterogeneity in Surrogacy Using Censored DataJournal2024DPPOS, DPP23555Secondary Research
Association of Perfluoroalkyl and Polyfluoroalkyl Substances With AdiposityJournal201810.1001/jamanetworkopen.2018.1493DPP, DPPOS20499Secondary Research
Can Earlier Biomarker Measurements Explain a Treatment Effect on Diabetes Incidence? A Robust Comparison of Four Surrogate MarkersJournal2023DPP, DPPOS23555Secondary Research
Comparison among criteria to define successful weight-loss maintainers and regainers in the Action for Health in Diabetes (Look AHEAD) and Diabetes Prevention Program trials.29046304PMC5698838Journal201710.3945/ajcn.117.157446DPPOS, DPP20943, 21251Secondary Research
Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.28803840PMC5769867Journal201710.1016/S2213-8587(17)30221-8DPP, DPPOS21387Secondary Research
Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors35339377Journal202210.1016/j.jdiacomp.2022.108180DPP, DPPOS, DCCT/EDIC, CRIC21415Secondary Research
Evaluating surrogate marker information using censored data.28088843PMC5413393Journal201710.1002/sim.7220DPP, DPPOS20673Secondary Research
First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes.18711387PMC2574826Journal200810.1038/ijo.2008.134DPPOSContributing Study
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.26377054PMC4623946Journal201510.1016/S2213-8587(15)00291-0DPPOSContributing Study
Quantifying the Feasibility of Shortening Clinical Trial Duration Using Surrogate Markers34474500PMC8595715Journal202110.1002/sim.9185DPP, DPPOS22454, 23555Secondary Research
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.11832527PMC1370926Journal200210.1056/NEJMoa012512DPP, DPPOSContributing Study
Robust Approach to Combining Multiple Markers to Improve Surrogacy35426444PMC10347081Journal202210.1111/biom.13677DPP, DPPOS22454, 23555Secondary Research
Using a Surrogate Marker for Early Testing of a Treatment EffectConference Presentation2019DPP, DPPOS23555Secondary Research
Weight Loss, Lifestyle Intervention, and Metformin Affect Longitudinal Relationship of Insulin Secretion and Sensitivity36062951PMC9923796Journal202210.1210/clinem/dgac509DPPOS, DPP21434Secondary Research
  • Previous
  • 1(current)
  • Next
Page